Related News

New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials

Jul 30, 2015

Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily

Novel Microendoscope Ups Accuracy of Esophageal Screening

Jul 29, 2015

Low-cost HRME ups accuracy of Lugol's chromoendoscopy for esophageal cancer

ASCO Calls for Cancer Trials to Include More Seniors

Jul 30, 2015

Older adults react differently to treatment, oncology group notes

Frequently Asked Questions